Modulation of kynurenic acid synthesis in rodent models of retinal degeneration

Informations projet

REJDAK, ROBERT

N° de convention de subvention: QLK2-CT-2002-51562

Projet clôturé

Date de début 1 Janvier 2003

Date de fin 31 Decembre 2004

Financé au titre de

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coût total € 147 150,00

Contribution de l’UE € 147 150,00

Coordonné par

THE UNIVERSITY OF TUEBINGEN
Germany

Objectif

Gynogenic acid (KYNA) may act as a neuroprotectant against retinal degeneration. I will investigate modulation of its retinal content and the expression and cellular distribution of key enzymes of KYNA synthesis kynurenine ammotransferases I and II (KAT I and II) in rodent models of optic nerve trauma, glaucoma and diabetic retinopathy

Champ scientifique

• medical and health sciences › clinical medicine › ophthalmology › glaucoma
• medical and health sciences › clinical medicine › ophthalmology › retinopathy
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thème(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Appel à propositions

Data not available

Régime de financement

RGI - Research grants (individual fellowships)

Coordinateur

THE UNIVERSITY OF TUEBINGEN

• Contribution de l’UE: Aucune donnée
• Adresse: Roentgenweg, 11 ; 72076 TUEBINGEN ; Allemagne
• Coût total: Aucune donnée